ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NIH News: PubMed Central Is Name Of New NIH PLAN For Electronic Publishing

September 10, 1999

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983